Skip to main content
. 2005 Jun;43(6):2729–2735. doi: 10.1128/JCM.43.6.2729-2735.2005

TABLE 2.

Demographic and clinical characteristics of the patients with positive cultures for C. parapsilosis in the NICU from September 2000 to December 2001

Variable Patients with BSIs (cases; n = 10)a Patients without BSIs (noncases; n = 39)a
P valueb
Patients with superficial infections (n = 15) Patients with colonization (n = 24)
Baseline characteristics
    Birth weight (g [range]) 665 (480-830) 810 (360-1,200) 895 (440-1,410) <0.01
    Gestational age (wk [range]) 25 (24-27) 27 (25-29) 27 (23-32) <0.001
    Male sex (no. [%] of patients) 7 (70) 8 (53) 15 (63) 0.72
    Antenatal antibiotics (no. [%] of patients) 5 (50) 5 (33) 8 (33) 0.46
    Vaginal delivery (no. [%] of patients) 5 (50) 5 (33) 8 (33) 0.46
    Apgar score (range) at 5 min of age 6 (3-8) 7 (2-10) 7 (3-9) 0.20
Factors associated with hospitalization
    Length of stay in the NICU (days [range])
        Total 86 (16-111) 58 (3-110) 42 (10-87) <0.01
        Before first CP isolationc 13 (9-33) 17 (4-45) 14 (4-36) 0.8
    Duration of mechanical ventilation (days [range])
        Total 48 (15-68) 12 (3-29) 14.5 (1-38) <0.001
        Before first CP isolationc 13 (9-33) 11 (3-28) 10.5 (1-33) 0.09
    Duration of PNd (days [range]) 13 (9-33) 16 (3-23) 14 (4-30) 0.5
    Duration (days [range]) of vascular accessd
        Umbilical catheter 4 (0-14) 0 (0-5) 0 (0-7) <0.01
        Arterial catheter 12.5 (6-17) 11 (0-17) 10 (3-16) 0.10
        Central venous catheter 9 (4-20) 10 (0-17) 6.5 (0-15) 0.15
    Treatment with antibioticsd (no. [%] of patients)
        Ampicillin-netilmicin 10 (100) 14 (97) 24 (100) 1.0
        Vancomycin and/or cephalosporins 10 (100) 13 (87) 22 (92) 0.57
        Fluconazole 5 (50) 4 (27) 9 (38) 0.48
        Amphotericin B 1 (10) 0 (0) 1 (4) 1.0
    Surgical proceduresd (no. [%] of patients) 5 (50) 2 (13) 8 (33) 0.25
    Mortalitye (no. [%] of patients) 1 (10) 0 (0) 3 (13) 1.0
a

Data on continuous variables are presented as medians (ranges).

b

Cases versus noncases, i.e., patients with BSI versus patients without BSIs.

c

From blood cultures (cases) or other cultures (noncases). CP, Candida parapsilosis.

d

Before first positive blood cultures (cases) or other cultures (noncases). PN, parenteral nutrition with lipids.

e

Within 7 days after a positive culture for C. parapsilosis.